|Table of Contents|

Research progress of MEX3A on tumor

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 08
Page:
1558-1562
Research Field:
Publishing date:

Info

Title:
Research progress of MEX3A on tumor
Author(s):
JU HaoHUANG Ying
Department of Ultrasound,Shengjing Hospital of China Medical University,Liaoning Shenyang 110004,China.
Keywords:
MEX3Atumormolecular marker
PACS:
R730
DOI:
10.3969/j.issn.1672-4992.2023.08.032
Abstract:
MEX3 proteins are a class of RNA-binding proteins that participates in a variety of physiological and pathological processes in human.With the advance of molecular biology and oncology,increasing evidence prove that MEX3A plays an important role in the pathogenesis and development of many kinds of tumor.MEX3A may become a molecular marker and therapeutic target for many tumors,providing new ideas and directions for the diagnosis and treatment of tumors.This paper reviews the structural and functional characteristics of MEX3A and its development in multiple tumors.

References:

[1] BUCHET-POYAU K,COURCHET J,LE HIR H,et al.Identification and characterization of human Mex-3 proteins,a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies[J].Nucleic Acids Res,2007,35(4):1289-1300.
[2] LEDERER M,MULLER S,GLASS M,et al.Oncogenic potential of the dual-function protein MEX3A[J].Biology (Basel),2021,10(5):415.
[3] CANO F,BYE H,DUNCAN LM,et al.The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation[J].EMBO J,2012,31(17):3596-3606.
[4] BULATOV E,VALIULLINA A,SAYAROVA R,et al.Promising new therapeutic targets for regulation of inflammation and immunity:RING-type E3 ubiquitin ligases[J].Immunol Lett,2018,202:44-51.
[5] MOUDUDEE SA,JIANG Y,GILBERT N,et al.Structural and functional characterization of hMEX-3C Ring finger domain as an E3 ubiquitin ligase[J].Protein Sci,2018,27(9):1661-1669.
[6] 刘占伟,祖恩霞,潘跃银,等.miR-194-5p靶向MEX3A调控肝癌细胞活性和凋亡的机制[J].中国老年学杂志,2019,39(18):4551-4555. LIU ZW,ZU EX,PAN YY,et al.Mechanism of miR-194-5p targeting MEX3A to regulate hepatoma cell activity and apoptosis[J].Chinese Journal of Gerontology,2019,39(18):4551-4555.
[7] KREPISCHI ACV,MASCHIETTO M,FERREIRA EN,et al.Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors[J].Mol Cytogenet,2016,9:20.
[8] LIAO Z,HU C,GAO Y.Mechanisms modulating the activities of intestinal stem cells upon radiation or chemical agent exposure[J].J Radiat Res,2022,63(2):149-157.
[9] SANTOVITO D,EGEA V,BIDZHEKOV K,et al.Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis[J].Sci Transl Med,2020,12(546):eaaz2294.
[10] BAUMGART M,GROTH M,PRIEBE S,et al.RNA-seq of the aging brain in the short-lived fish N.furzeri - conserved pathways and novel genes associated with neurogenesis[J].Aging Cell,2014,13(6):965-974.
[11] BARRIGA FM,MONTAGNI E,MANA M,et al.Mex3a marks a slowly dividing subpopulation of Lgr5+ intestinal stem cells[J].Cell Stem Cell,2017,20(6):801-816.e7.
[12] YANG Y,WANG SY,HUANG ZF,et al.The RNA-binding protein Mex3B is a coreceptor of Toll-like receptor 3 in innate antiviral response[J].Cell Res,2016,26(3):288-303.
[13] 王俊钢,李聪聪,毛广显,等.miR-210调控Mex3B蛋白对肺癌细胞侵袭和增殖的影响[J].中国免疫学杂志,2017,33(10):1468-1473. WANG JG,LI CC,MAO GX,et al.miR-210 regulates the effects of Mex3B protein on invasion and proliferation of lung cancer cells[J].Chinese Journal of Immunology,2017,33(10):1468-1473.
[14] CANO F,MIRANDA-SAAVEDRA D,LEHNER PJ.RNA-binding E3 ubiquitin ligases:novel players in nucleic acid regulation[J].Biochem Soc Trans,2010,38(6):1621-1626.
[15] BURRELL RA,MCCLELLAND SE,ENDESFELDER D,et al.Replication stress links structural and numerical cancer chromosomal instability[J].Nature,2013,494(7438):492-496.
[16] CAO Y,JIANG F,ZHANG S,et al.MEX3C promotes osteosarcoma malignant progression through negatively regulating FGF14[J].J BUON,2020,25(3):1554-1561.
[17] 杨玲玲,马会明,赵帅,等.MEX3C基因缺失对小鼠产仔数和卵泡发育的影响[J].宁夏医学杂志,2020,42(1):15-17. YANG LL,MA HM,ZHAO S,et al.Effects of MEX3C gene deletion on litter size and follicle development in mice[J].Ningxia Medical Journal,2020,42(1):15-17.
[18] SHAO L,WANG J,KARATAS O,et al.MEX3D is an oncogenic driver in prostate cancer[J].Prostate,2021,81(15):1202-1213.
[19] PARISI C,GIORGI C,BATASSA EM,et al.Ago1 and Ago2 differentially affect cell proliferation,motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells[J].FEBS Lett,2011,585(19):2965-2971.
[20] JASINSKI-BERGNER S,STEVEN A,SELIGER B.The role of the RNA-binding protein family MEX-3 in tumorigenesis[J].Int J Mol Sci,2020,21(15):5209.
[21] YANG C,ZHAN H,ZHAO Y,et al.MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2[J].Cell Death Dis,2021,12(1):14.
[22] WEI L,WANG B,HU L,et al.MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6[J].Aging (Albany NY),2020,12(21):21091-21113.
[23] JIANG H,ZHANG X,LUO J,et al.Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells[J].Mol Med Rep,2012,6(3):575-580.
[24] YANG D,JIAO Y,LI Y,et al.Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer[J].Peer J,2020,8:e8252.
[25] DING J,HE X,LUO W,et al.Development and validation of a pyroptosis-related signature for predicting prognosis in hepatocellular carcinoma[J].Front Genet,2022,13:801419.
[26] WANG X,SHAN YQ,TAN QQ,et al.MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma[J].Cancer Cell Int,2020,20:63.
[27] PANZERI V,MANNI I,CAPONE A,et al.The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma[J].Mol Oncol,2021,15(2):579-595.
[28] KONUKIEWITZ B,SCHMITT M,SILVA M,et al.Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classification[J].Br J Cancer,2021,125(12):1632-1646.
[29] YU J,LIU D,SUN X,et al.CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/beta-catenin signaling via transactivation of GSK-3beta and Axin2 expression[J].Cell Death Dis,2019,10(1):26.
[30] ZHOU X,LI S,MA T,et al.MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression[J].Exp Ther Med,2021,22(5):1343.
[31] CHATTERJI P,RUSTGI AK.RNA binding proteins in intestinal epithelial biology and colorectal cancer[J].Trends Mol Med,2018,24(5):490-506.
[32] FERNANDEZ-BARRAL A,COSTALES-CARRERA A,BUIRA SP,et al.Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids[J].FEBS J,2020,287(1):53-72.
[33] PEREIRA B,SOUSA S,BARROS R,et al.CDX2 regulation by the RNA-binding protein MEX3A:impact on intestinal differentiation and stemness[J].Nucleic Acids Res,2013,41(7):3986-3999.
[34] 陈云云,房超,于秋爽,等.MEX3A在人膀胱癌组织细胞中的表达及分析[J].生物医学工程与临床,2018,22(1):82-86. CHEN YY,FANG C,YU QS,et al.MEX3A expression and analysis in human bladder cancer cells[J].Biomedical Engineering and Clinical,2018,22(1):82-86.
[35] LIN KY,ZHANG XJ,FENG DD,et al.miR-125b,a target of CDX2,regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies[J].J Biol Chem,2011,286(44):38253-38263.
[36] LIU S,CHEN Q,WANG Y.MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway[J].Hum Cell,2020,33(1):185-194.
[37] LI D,HAO X,SONG Y.An integrated analysis of key microRNAs,regulatory pathways and clinical relevance in bladder cancer[J].Onco Targets Ther,2018,11:3075-3085.
[38] 房超,尹晶,于秋爽,等.RNA干扰MEX3A基因对膀胱癌细胞增殖和凋亡的影响[J].解剖学报,2017,48(6):688-692. FANG C,YIN J,YU QS,et al.Effects of RNA interference with MEX3A gene on proliferation and apoptosis of bladder cancer cells[J].Journal of Anatomy,2017,48(6):688-692.
[39] HUANG Y,FANG C,SHI JW,et al.Identification of hMex-3A and its effect on human bladder cancer cell proliferation[J].Oncotarget,2017,8(37):61215-61225.
[40] SHI JW,HUANG Y.Mex3a expression and survival analysis of bladder urothelial carcinoma[J].Oncotarget,2017,8(33):54764-54774.
[41] QIU Y,MENG M,CAO C,et al.RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma[J].Mol Ther Nucleic Acids,2022,27:241-255.
[42] 燕旭靖,李红娟,梅琳琳,等.MEX3A蛋白在上皮性卵巢癌组织中的表达及临床意义[J].现代妇产科进展,2019,28(5):373-374,377. YAN XJ,LI HJ,MEI LL,et al.MEX3A expression and clinical significance in epithelial ovarian cancer[J].Progress in Modern Obstetrics and Gynecology,2019,28(5):373-374,377.
[43] BUFALIERI F,CAIMANO M,LOSPINOSO SEVERINI L,et al.The RNA-binding ubiquitin ligase MEX3A affects glioblastoma tumorigenesis by inducing ubiquitylation and degradation of RIG-I[J].Cancers (Basel),2020,12(2):321.
[44] JIANG S,MENG L,CHEN X,et al.MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway[J].Exp Cell Res,2020,395(2):112191.
[45] LIANG J,LI H,HAN J,et al.Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway[J].Cell Death Dis,2020,11(8):614.
[46] KNIGHT T,LUEDTKE D,EDWARDS H,et al.A delicate balance:The BCL-2 family and its role in apoptosis,oncogenesis,and cancer therapeutics[J].Biochem Pharmacol,2019,162:250-261.
[47] SCHAFER C,SEELIGER H,BADER DC,et al.Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma[J].J Cell Mol Med,2012,16(8):1776-1791.
[48] MOMENY M,ALISHAHI Z,EYVANI H,et al.Anti-tumor activity of cediranib,a pan-vascular endothelial growth factor receptor inhibitor,in pancreatic ductal adenocarcinoma cells[J].Cell Oncol (Dordr),2020,43(1):81-93.
[49] DAVID CJ,HUANG YH,CHEN M,et al.TGF-beta tumor suppression through a lethal EMT[J].Cell,2016,164(5):1015-1030.
[50] AIELLO NM,KANG Y.Context-dependent EMT programs in cancer metastasis[J].J Exp Med,2019,216(5):1016-1026.
[51] GLAS M,COCH C,TRAGESER D,et al.Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma[J].Stem Cells,2013,31(6):1064-1074.
[52] WU Y,WU X,WU L,et al.The anticancer functions of RIG-I-like receptors,RIG-I and MDA5,and their applications in cancer therapy[J].Transl Res,2017,190:51-60.
[53] XU XX,WAN H,NIE L,et al.RIG-I:a multifunctional protein beyond a pattern recognition receptor[J].Protein Cell,2018,9(3):246-253.
[54] LIU F,KORC M.Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells[J].Mol Cancer Ther,2012,11(10):2138-2148.
[55]LI H,LIANG J,WANG J,et al.Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p[J].Cancer Commun (Lond),2021,41(6):472-491.

Memo

Memo:
-
Last Update: 1900-01-01